Pharmadule Morimatsu poised to benefit from pharma trend to modular design


Pharmadule Morimatsu poised to benefit from pharma trend to modular design


Pharmadule Morimatsu Logo 150 x 48

Press Release | Pharmadule Morimatsu AB

AUGUST 15, 2017

Nacka, Stockholm: – Pharmadule Morimatsu AB (Pharmadule), the Swedish-based specialist in modular facilities and process equipments, has seen its modular design and construction vision and methodology validated by key players in the pharmaceutical industry.

Pharmadule’s Director of Business Development Leo Fallgren commented: “We found more and more interest in modular designs and modular process equipment and facilities. This is a indication that Pharmadule has listened to its customers needs and is well positioned to serve them on a global basis.

Mr. Fallgren also said he had encountered similar interest in modular facility provision and modular construction during his recent travels across Europe, with a noticeable uptake in enquiries and approaches concerning Pharmadule’s modular services. Mr. Fallgren credits the increase in interest with Pharmadule’s modular design services due to the fact modular projects are handled quite differently from traditional plant construction projects and require a completely different approach in planning through to execution.

Pharmadule’s unique approach with a focus on engineering and fabrication means they are well positioned to cater for this shift to modular construction.

Long term savings

“This confirms a big trend for companies to go more modular with designs, process equipments and facilities,” said Pharmadule.

“The global pharma player sees the benefit in a faster and predictable modular approach,” the company said.

Pharmadule pointed out that while set up costs may be higher, the modular design and construction was much more cost effective over the overall duration of the project, with more than sufficient overall cost savings to outweigh increased initial investment.

Timeframes for modular projects tend to be much shorter than those of traditional engineering and construction projects. Also commissioning, qualification and validation are all part of the modular design process rather than separate stages as in a traditional project.

Due to the difference between modular and traditional construction projects it is imperative to work with a partner who understands and is experienced in the initial design and planning stage in modular construction. As a result Pharmadule is well positioned to help support partners with their modular construction and design enquiries.

About Pharmadule Morimatsu

Pharmadule Morimatsu designs and builds turnkey production facilities and process equipment’s for the pharma – biopharma Industries and also for the FMCG area (Fast Moving Consumer Goods). Pharmadule services extend from conceptual design to IQOQ qualifications completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance (QA) and Validation Management.

The company was founded in September 1986 by engineer Clas Wallenborg whose vision was to use the same basic modular design techniques and technology used to build specialized spaces for offshore oil platforms to be able to deliver ‘ready made’ hygienic pharmaceutical production and laboratory facilities worldwide. These could be designed and fabricated centrally under hi-tech controlled conditions and transported to pharma sites all over the world for final assembly and erection.

Since then, Pharmadule has successfully delivered more than 70 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pfizer, AstraZeneca, forging The Pharmadule Way as a way of offering unique value and reassurance to customers, with off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality, regardless of final location.

Since 2011, Pharmadule has been part of the Morimatsu Group of Japan, which specializes in process equipment, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.

Media Contact

Leo Fällgren, Director Business Development, Pharmadule Morimatsu AB
Tel: +46 (0)8 587 42 000
Email: Leo.Fallgren@pharmadule.com

Resources

Click on Pharmadule Morimatsu sees trend to modular design for more information.
Click on Pharmadule to contact the company directly.

Merck & Co. 7,000m2 Vaccine and Biologics Sterile Facility (VBSF) in Carlow, Ireland: constructed and delivered by Pharmadule Morimatsu in 2010 and winner of ISPE Facility of the Year Award for Operational Excellence

Merck & Co. 7,000m2 Vaccine and Biologics Sterile Facility (VBSF) in Carlow, Ireland: constructed and delivered by Pharmadule Morimatsu in 2010 and winner of ISPE Facility of the Year Award for Operational Excellence

Pharmadule Morimatsu constructed Merck and Co VBSF in Carlow, Ireland, handles buffer preparation, formulation, vial and syringe filling of vaccines, along with inspection, component preparation and washing

Pharmadule Morimatsu constructed Merck and Co VBSF in Carlow, Ireland, handles buffer preparation, formulation, vial and syringe filling of vaccines, along with inspection, component preparation and washing

Modular construction in action: Pharmadule Morimatsu delivers aseptic filling plant expansion for Astra Zeneca in Wuxi, China in 2009

Modular construction in action: Pharmadule Morimatsu delivers aseptic filling plant expansion for Astra Zeneca in Wuxi, China in 2009


Supplier Information
Supplier: Pharmadule Morimatsu AB
Address: DanvikCenter 28, SE – 131 30 Nacka, Sweden
Tel: +46 (0)8 587 42 000
Website: www.pharmadule.com


Comments are closed.